Flagship explainer
How Amylyx Pharmaceuticals, Inc. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $0 | Unavailable |
| |
| Cost of revenue | $0 | Unavailable |
|
| $0 | Unavailable |
| |
| −$153M | Unavailable |
| |
| Income before tax | −$145M | Unavailable |
|
| Income tax | $46000 | Unavailable |
|
| −$145M | Unavailable |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001193125-26-086645